Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Chun-Yiu Chan

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Fundamental Research|December 30, 2025
Tailoring combinational therapy with Monte Carlo method-based regression modelingBoqian Wang, Shuofeng Yuan, Chris Chun-Yiu Chan, et al.
Metabolites|July 29, 2020
Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in <i>Enterovirus</i>-Infected CellsZijiao Zou, Jessica Oi-Ling Tsang, Bingpeng Yan, et al.
Computational and Structural Biotechnology Journal|October 29, 2021
Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targetsJianli Cao, Gang Lu, Lei Wen, et al.
International Journal of Biological Sciences|April 28, 2021
<i>In silico</i> structure-based discovery of a SARS-CoV-2 main protease inhibitorLei Wen, Kaiming Tang, Kenn Ka-Heng Chik, et al.
Viruses|April 28, 2019
Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome VirusShuofeng Yuan, Jasper Fuk-Woo Chan, Zi-Wei Ye, et al.
Emerging Microbes & Infections|February 4, 2021
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infectionZi-Wei Ye, Shuofeng Yuan, Jasper Fuk-Woo Chan, et al.
Viruses|June 14, 2020
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)Shuofeng Yuan, Chris Chun-Yiu Chan, Kenn Ka-Heng Chik, et al.
Nature Communications|May 9, 2022
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamstersWei Qiao, Hui En Lau, Huizhi Xie, et al.
Nature Communications|May 31, 2022
Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamstersWei Qiao, Hui En Lau, Huizhi Xie, et al.
Research Square|October 14, 2020
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamstersShuofeng Yuan, Xin Yin, XiangZhi Meng, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Fundamental Research|December 30, 2025
Tailoring combinational therapy with Monte Carlo method-based regression modelingBoqian Wang, Shuofeng Yuan, Chris Chun-Yiu Chan, et al.
Metabolites|July 29, 2020
Metabolic Profiling Reveals Significant Perturbations of Intracellular Glucose Homeostasis in <i>Enterovirus</i>-Infected CellsZijiao Zou, Jessica Oi-Ling Tsang, Bingpeng Yan, et al.
Computational and Structural Biotechnology Journal|October 29, 2021
Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targetsJianli Cao, Gang Lu, Lei Wen, et al.
International Journal of Biological Sciences|April 28, 2021
<i>In silico</i> structure-based discovery of a SARS-CoV-2 main protease inhibitorLei Wen, Kaiming Tang, Kenn Ka-Heng Chik, et al.
Viruses|April 28, 2019
Screening of an FDA-Approved Drug Library with a Two-Tier System Identifies an Entry Inhibitor of Severe Fever with Thrombocytopenia Syndrome VirusShuofeng Yuan, Jasper Fuk-Woo Chan, Zi-Wei Ye, et al.
Emerging Microbes & Infections|February 4, 2021
Beneficial effect of combinational methylprednisolone and remdesivir in hamster model of SARS-CoV-2 infectionZi-Wei Ye, Shuofeng Yuan, Jasper Fuk-Woo Chan, et al.
Viruses|June 14, 2020
Broad-Spectrum Host-Based Antivirals Targeting the Interferon and Lipogenesis Pathways as Potential Treatment Options for the Pandemic Coronavirus Disease 2019 (COVID-19)Shuofeng Yuan, Chris Chun-Yiu Chan, Kenn Ka-Heng Chik, et al.
Nature Communications|May 9, 2022
SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamstersWei Qiao, Hui En Lau, Huizhi Xie, et al.
Nature Communications|May 31, 2022
Author Correction: SARS-CoV-2 infection induces inflammatory bone loss in golden Syrian hamstersWei Qiao, Hui En Lau, Huizhi Xie, et al.
Research Square|October 14, 2020
Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamstersShuofeng Yuan, Xin Yin, XiangZhi Meng, et al.
Pageof 2